199 related articles for article (PubMed ID: 9743517)
1. Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery.
Rechavia E; Wurzel M
Circulation; 1998 Sep; 98(12):1249-50. PubMed ID: 9743517
[No Abstract] [Full Text] [Related]
2. [Lysis of an intracoronary thrombus with a glycoprotein IIb/IIIa antagonist].
Ammann P; Naegeli B; Schuiki E; Bertel O
Schweiz Med Wochenschr; 2000 Mar; 130(9):336. PubMed ID: 10746274
[No Abstract] [Full Text] [Related]
3. Use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Parmar R; Stouffer GA
Am J Med Sci; 1997 Jul; 314(1):31-6. PubMed ID: 9216438
[No Abstract] [Full Text] [Related]
4. The glycoprotein IIb/IIIa receptor inhibitor (abciximab) in ST-segment elevation myocardial infarction.
Mesquita A; Baptista J; Palos J; Seabra-Gomes R
J Invasive Cardiol; 1999 Jun; 11(6):379-82. PubMed ID: 10745556
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies in cardiology].
Legrand V
Rev Med Liege; 2009; 64(5-6):310-2. PubMed ID: 19642465
[TBL] [Abstract][Full Text] [Related]
6. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
EPISTENT Investigators
Lancet; 1998 Jul; 352(9122):87-92. PubMed ID: 9672272
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein inhibitors and fibrinolysis in myocardial infarction.
Ring BL
JAMA; 2000 Dec; 284(24):3124-5. PubMed ID: 11135766
[No Abstract] [Full Text] [Related]
8. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.
Neumann FJ; Blasini R; Schmitt C; Alt E; Dirschinger J; Gawaz M; Kastrati A; Schömig A
Circulation; 1998 Dec; 98(24):2695-701. PubMed ID: 9851955
[TBL] [Abstract][Full Text] [Related]
9. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
[TBL] [Abstract][Full Text] [Related]
10. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Lincoff AM; Tcheng JE; Califf RM; Kereiakes DJ; Kelly TA; Timmis GC; Kleiman NS; Booth JE; Balog C; Cabot CF; Anderson KM; Weisman HF; Topol EJ
Circulation; 1999 Apr; 99(15):1951-8. PubMed ID: 10208997
[TBL] [Abstract][Full Text] [Related]
11. Images in cardiovascular medicine. Rapid dissolution of massive intracoronary thrombosis with platelet glycoprotein IIb/IIIa receptor inhibitor.
Rerkpattanapipat P; Kotler MN; Yazdanfar S
Circulation; 1999 Jun; 99(22):2965. PubMed ID: 10359744
[No Abstract] [Full Text] [Related]
12. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease.
Etheridge SP; Tani LY; Minich LL; Revenaugh JR
Cathet Cardiovasc Diagn; 1998 Nov; 45(3):264-8. PubMed ID: 9829884
[TBL] [Abstract][Full Text] [Related]
13. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
Ronner E; Dykun Y; van den Brand MJ; van der Wieken LR; Simoons ML
Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912
[No Abstract] [Full Text] [Related]
14. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].
Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B
Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204
[TBL] [Abstract][Full Text] [Related]
15. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
Khan SS; Forrester J
N Engl J Med; 1997 Oct; 337(17):1243; author reply 1244-5. PubMed ID: 9340527
[No Abstract] [Full Text] [Related]
16. Images in cardiovascular medicine. IIb/IIIa receptor antagonists for failed rescue angioplasty.
Ronner E; van der Wieken LR; Slagboom TS; Laarman GJ; Kiemeneij F
Circulation; 2000 Jan; 101(2):214-5. PubMed ID: 10637211
[No Abstract] [Full Text] [Related]
17. Improving microvascular perfusion with platelet glycoprotein IIb/IIIa receptor inhibition.
Dippel EJ
J Invasive Cardiol; 2002 Dec; 14 Suppl E():12E-16E; quiz 17E. PubMed ID: 12668858
[TBL] [Abstract][Full Text] [Related]
18. Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Young JJ
J Invasive Cardiol; 2005 Jun; 17(6):300-1. PubMed ID: 16003003
[No Abstract] [Full Text] [Related]
19. Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade.
Ghaffari S; Kereiakes DJ; Lincoff AM; Kelly TA; Timmis GC; Kleiman NS; Ferguson JJ; Miller DP; Califf RA; Topol EJ
Am J Cardiol; 1998 Jul; 82(1):7-12. PubMed ID: 9671000
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
Mukherjee D; Roffi M
J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
